chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 73.0
Sex: F
Vaccine: COVID19-2, DTAPIPVHIB, COVID19
Symptoms: Arthralgia, Chills, Cold sweat, Dizziness, Feeling cold
Clinical narrative: Very cold; shivering; very painful right arm can't move right arm; headache; joint pain; dizziness; nausea; very dry mouth; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 73-year-old female patient (not pregnant) received bnt162b2 (BNT162B2), on 18Sep2023 at 10:45 as dose 1, single (Batch/Lot number: unknown) at the age of 73 years, in right arm for covid-19 immunisation. The patient's relevant medical history included: "Arthritis" (unspecified if ongoing); "colon issues" (unspecified if ongoing); "recent rotator cuff surgery" (unspecified if ongoing), notes: recent rotator cuff surgery. Concomitant medication(s) included: ETODOLAC; LINZESS; LORAZEPAM; OMEPRAZOL; SHINGRIX taken for immunisation, start date: 11Aug2023, stop date: 11Aug2023. Past drug history included: Flagyl, reaction(s): "Allergy: Flagyl"; Ciprofloxacin, reaction(s): "Allergy: Ciprofloxacin"; Cefuroxime, reaction(s): "Allergy: cefuroxime"; Cortizone, reaction(s): "Allergy: cortizone". The following information was reported: NASOPHARYNGITIS (non-serious) with onset 18Sep2023 at 12:00, outcome "recovered with sequelae", described as "Very cold"; DIZZINESS (non-serious) with onset 18Sep2023 at 12:00, outcome "recovered with sequelae"; HEADACHE (non-serious) with onset 18Sep2023 at 12:00, outcome "recovered with sequelae"; ARTHRALGIA (non-serious) with onset 18Sep2023 at 12:00, outcome "recovered with sequelae", described as "joint pain"; NAUSEA (non-serious) with onset 18Sep2023 at 12:00, outcome "recovered with sequelae"; CHILLS (non-serious) with onset 18Sep2023 at 12:00, outcome "recovered with sequelae", described as "shivering"; DRY MOUTH (non-serious) with onset 18Sep2023 at 12:00, outcome "recovered with sequelae", described as "very dry mouth"; PAIN IN EXTREMITY (non-serious) with onset 18Sep2023 at 12:00, outcome "recovered with sequelae", described as "very painful right arm can't move right arm". The events "very cold", "shivering", "very painful right arm can't move right arm", "headache", "joint pain", "dizziness", "nausea" and "very dry mouth" required emergency room visit. Therapeutic measures were taken as a result of nasopharyngitis, chills, pain in extremity, headache, arthralgia, dizziness, nausea, dry mouth.  Additional Information: The patient received other vaccine in 4 weeks and other medication in two weeks. Tylenol and Ibuprofen was given as treatment for the events. Patient was not tested for covid prior or post vaccination .Patient recovered with lasting effects.  The information on the batch/lot number for bnt162b2 has been requested and will be submitted if and when received.
Age: 73.0
Sex: F
Vaccine: COVID19-2, DTAPIPVHIB, COVID19
Symptoms: Headache, Injection site pain, Nausea, Procedural pain
Clinical narrative: Very cold; shivering; very painful right arm can't move right arm; headache; joint pain; dizziness; nausea; very dry mouth; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 73-year-old female patient (not pregnant) received bnt162b2 (BNT162B2), on 18Sep2023 at 10:45 as dose 1, single (Batch/Lot number: unknown) at the age of 73 years, in right arm for covid-19 immunisation. The patient's relevant medical history included: "Arthritis" (unspecified if ongoing); "colon issues" (unspecified if ongoing); "recent rotator cuff surgery" (unspecified if ongoing), notes: recent rotator cuff surgery. Concomitant medication(s) included: ETODOLAC; LINZESS; LORAZEPAM; OMEPRAZOL; SHINGRIX taken for immunisation, start date: 11Aug2023, stop date: 11Aug2023. Past drug history included: Flagyl, reaction(s): "Allergy: Flagyl"; Ciprofloxacin, reaction(s): "Allergy: Ciprofloxacin"; Cefuroxime, reaction(s): "Allergy: cefuroxime"; Cortizone, reaction(s): "Allergy: cortizone". The following information was reported: NASOPHARYNGITIS (non-serious) with onset 18Sep2023 at 12:00, outcome "recovered with sequelae", described as "Very cold"; DIZZINESS (non-serious) with onset 18Sep2023 at 12:00, outcome "recovered with sequelae"; HEADACHE (non-serious) with onset 18Sep2023 at 12:00, outcome "recovered with sequelae"; ARTHRALGIA (non-serious) with onset 18Sep2023 at 12:00, outcome "recovered with sequelae", described as "joint pain"; NAUSEA (non-serious) with onset 18Sep2023 at 12:00, outcome "recovered with sequelae"; CHILLS (non-serious) with onset 18Sep2023 at 12:00, outcome "recovered with sequelae", described as "shivering"; DRY MOUTH (non-serious) with onset 18Sep2023 at 12:00, outcome "recovered with sequelae", described as "very dry mouth"; PAIN IN EXTREMITY (non-serious) with onset 18Sep2023 at 12:00, outcome "recovered with sequelae", described as "very painful right arm can't move right arm". The events "very cold", "shivering", "very painful right arm can't move right arm", "headache", "joint pain", "dizziness", "nausea" and "very dry mouth" required emergency room visit. Therapeutic measures were taken as a result of nasopharyngitis, chills, pain in extremity, headache, arthralgia, dizziness, nausea, dry mouth.  Additional Information: The patient received other vaccine in 4 weeks and other medication in two weeks. Tylenol and Ibuprofen was given as treatment for the events. Patient was not tested for covid prior or post vaccination .Patient recovered with lasting effects.  The information on the batch/lot number for bnt162b2 has been requested and will be submitted if and when received.
Age: 73.0
Sex: F
Vaccine: COVID19-2, DTAPIPVHIB, COVID19
Symptoms: Arthralgia, Chills, Dizziness, Dry mouth, Headache
Clinical narrative: Very cold; shivering; very painful right arm can't move right arm; headache; joint pain; dizziness; nausea; very dry mouth; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 73-year-old female patient (not pregnant) received bnt162b2 (BNT162B2), on 18Sep2023 at 10:45 as dose 1, single (Batch/Lot number: unknown) at the age of 73 years, in right arm for covid-19 immunisation. The patient's relevant medical history included: "Arthritis" (unspecified if ongoing); "colon issues" (unspecified if ongoing); "recent rotator cuff surgery" (unspecified if ongoing), notes: recent rotator cuff surgery. Concomitant medication(s) included: ETODOLAC; LINZESS; LORAZEPAM; OMEPRAZOL; SHINGRIX taken for immunisation, start date: 11Aug2023, stop date: 11Aug2023. Past drug history included: Flagyl, reaction(s): "Allergy: Flagyl"; Ciprofloxacin, reaction(s): "Allergy: Ciprofloxacin"; Cefuroxime, reaction(s): "Allergy: cefuroxime"; Cortizone, reaction(s): "Allergy: cortizone". The following information was reported: NASOPHARYNGITIS (non-serious) with onset 18Sep2023 at 12:00, outcome "recovered with sequelae", described as "Very cold"; DIZZINESS (non-serious) with onset 18Sep2023 at 12:00, outcome "recovered with sequelae"; HEADACHE (non-serious) with onset 18Sep2023 at 12:00, outcome "recovered with sequelae"; ARTHRALGIA (non-serious) with onset 18Sep2023 at 12:00, outcome "recovered with sequelae", described as "joint pain"; NAUSEA (non-serious) with onset 18Sep2023 at 12:00, outcome "recovered with sequelae"; CHILLS (non-serious) with onset 18Sep2023 at 12:00, outcome "recovered with sequelae", described as "shivering"; DRY MOUTH (non-serious) with onset 18Sep2023 at 12:00, outcome "recovered with sequelae", described as "very dry mouth"; PAIN IN EXTREMITY (non-serious) with onset 18Sep2023 at 12:00, outcome "recovered with sequelae", described as "very painful right arm can't move right arm". The events "very cold", "shivering", "very painful right arm can't move right arm", "headache", "joint pain", "dizziness", "nausea" and "very dry mouth" required emergency room visit. Therapeutic measures were taken as a result of nasopharyngitis, chills, pain in extremity, headache, arthralgia, dizziness, nausea, dry mouth.  Additional Information: The patient received other vaccine in 4 weeks and other medication in two weeks. Tylenol and Ibuprofen was given as treatment for the events. Patient was not tested for covid prior or post vaccination .Patient recovered with lasting effects.  The information on the batch/lot number for bnt162b2 has been requested and will be submitted if and when received.
Age: 73.0
Sex: F
Vaccine: COVID19-2, DTAPIPVHIB, COVID19
Symptoms: Nasopharyngitis, Nausea, Pain in extremity
Clinical narrative: Very cold; shivering; very painful right arm can't move right arm; headache; joint pain; dizziness; nausea; very dry mouth; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 73-year-old female patient (not pregnant) received bnt162b2 (BNT162B2), on 18Sep2023 at 10:45 as dose 1, single (Batch/Lot number: unknown) at the age of 73 years, in right arm for covid-19 immunisation. The patient's relevant medical history included: "Arthritis" (unspecified if ongoing); "colon issues" (unspecified if ongoing); "recent rotator cuff surgery" (unspecified if ongoing), notes: recent rotator cuff surgery. Concomitant medication(s) included: ETODOLAC; LINZESS; LORAZEPAM; OMEPRAZOL; SHINGRIX taken for immunisation, start date: 11Aug2023, stop date: 11Aug2023. Past drug history included: Flagyl, reaction(s): "Allergy: Flagyl"; Ciprofloxacin, reaction(s): "Allergy: Ciprofloxacin"; Cefuroxime, reaction(s): "Allergy: cefuroxime"; Cortizone, reaction(s): "Allergy: cortizone". The following information was reported: NASOPHARYNGITIS (non-serious) with onset 18Sep2023 at 12:00, outcome "recovered with sequelae", described as "Very cold"; DIZZINESS (non-serious) with onset 18Sep2023 at 12:00, outcome "recovered with sequelae"; HEADACHE (non-serious) with onset 18Sep2023 at 12:00, outcome "recovered with sequelae"; ARTHRALGIA (non-serious) with onset 18Sep2023 at 12:00, outcome "recovered with sequelae", described as "joint pain"; NAUSEA (non-serious) with onset 18Sep2023 at 12:00, outcome "recovered with sequelae"; CHILLS (non-serious) with onset 18Sep2023 at 12:00, outcome "recovered with sequelae", described as "shivering"; DRY MOUTH (non-serious) with onset 18Sep2023 at 12:00, outcome "recovered with sequelae", described as "very dry mouth"; PAIN IN EXTREMITY (non-serious) with onset 18Sep2023 at 12:00, outcome "recovered with sequelae", described as "very painful right arm can't move right arm". The events "very cold", "shivering", "very painful right arm can't move right arm", "headache", "joint pain", "dizziness", "nausea" and "very dry mouth" required emergency room visit. Therapeutic measures were taken as a result of nasopharyngitis, chills, pain in extremity, headache, arthralgia, dizziness, nausea, dry mouth.  Additional Information: The patient received other vaccine in 4 weeks and other medication in two weeks. Tylenol and Ibuprofen was given as treatment for the events. Patient was not tested for covid prior or post vaccination .Patient recovered with lasting effects.  The information on the batch/lot number for bnt162b2 has been requested and will be submitted if and when received.
Sex: F
Vaccine: HPV9
Symptoms: Rash, Vaccination site rash
Clinical narrative: rash down her arm after vaccinated; This spontaneous report was received from a medical assistant referring an approximately 13-year-old female patient. The patient's concurrent conditions, historical conditions, concomitant therapies, allergies, and risk factors were not reported.  On an unknown date, the patient was vaccinated with hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) injection, administered intramuscularly (IM) as prophylaxis (dose, vaccination scheme frequency, anatomical location, lot number and expiration date were not reported). On 13-AUG-2023, the patient had her last menstrual period.  On 15-AUG-2023, the patient experienced rash down her arm after vaccinated with first dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) (Vaccination site rash). At the time of reporting, the outcome of the event was not provided.   The causal relationship between the event and hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) was unknown.
Age: 5.0
Sex: F
Vaccine: MMRV
Symptoms: Laboratory test, Lymphadenopathy, Mobility decreased, Pain
Clinical narrative: Lymphadenopathy; Unable to raise left arm; This spontaneous report was received from physician and referred to a non-pregnant 5-year-old female patient.  The patient's medical history, concurrent conditions and concomitant therapies were not reported.  On 13-SEP-2023, the patient was vaccinated with measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) injection, administered in the right arm for immunisation (strength, lot #, expiry date, vaccination scheme, and route of administration were not provided).  On 14-SEP-2023, (approximately 24h after receiving the suspect vaccine), the patient developed lymphadenopathy. She presented pain, lymph node swelling under the left arm (lymphadenopathy) and was unable to raise left arm (mobility decreased). Moreover, pain was "so bad" that on an unspecified day in September 2023, the patient sought medical attention and was admitted into the hospital. She received treatment due to the events. She was "having tests run" and it was unknown what testing the patient was having. At the reporting time, she had not recovered from the events.  The causal relationship between the events and measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) was unknown.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Heavy menstrual bleeding, Menstruation irregular, Muscle spasms
Clinical narrative: 1) Chills, aches, crumps, fatigue at a very intense level for 3 days after vaccination. 2) Menstrual issues - heavy bleeding, irregularity, shorter time between periods - resulting in low ferritin levels and related fatigue and other health problems - till today.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Polymenorrhoea, Serum ferritin decreased
Clinical narrative: 1) Chills, aches, crumps, fatigue at a very intense level for 3 days after vaccination. 2) Menstrual issues - heavy bleeding, irregularity, shorter time between periods - resulting in low ferritin levels and related fatigue and other health problems - till today.
Age: 56.0
Sex: M
Vaccine: FLUC4, UNK
Symptoms: Chills, Dizziness postural, Headache, Lethargy, Pain
Clinical narrative: fever, uncontrollable shivering, bad headache, all over body aches (hurts to move), lightheaded when standing, lethargy
Age: 56.0
Sex: M
Vaccine: FLUC4, UNK
Symptoms: Pyrexia
Clinical narrative: fever, uncontrollable shivering, bad headache, all over body aches (hurts to move), lightheaded when standing, lethargy
Age: 59.0
Sex: F
Vaccine: FLU4
Symptoms: Abdominal pain, Chills, Complex regional pain syndrome, Diarrhoea, Dizziness
Clinical narrative: Frontal headache was 1st symptom, followed severe nausea, retching, chills, generalized significant muscle pains, skin painful burning sensation and fatigue. A few hours later sever abdominal crps and diarrhea started, along with nausea again amd dizzinesa
Age: 59.0
Sex: F
Vaccine: FLU4
Symptoms: Fatigue, Headache, Myalgia, Nausea, Pain of skin
Clinical narrative: Frontal headache was 1st symptom, followed severe nausea, retching, chills, generalized significant muscle pains, skin painful burning sensation and fatigue. A few hours later sever abdominal crps and diarrhea started, along with nausea again amd dizzinesa
Age: 59.0
Sex: F
Vaccine: FLU4
Symptoms: Retching, Skin burning sensation
Clinical narrative: Frontal headache was 1st symptom, followed severe nausea, retching, chills, generalized significant muscle pains, skin painful burning sensation and fatigue. A few hours later sever abdominal crps and diarrhea started, along with nausea again amd dizzinesa
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Malaise, Weight decreased
Clinical narrative: sick spitting loss weight
Age: 62.0
Sex: F
Vaccine: COVID19-2
Symptoms: Biopsy skin abnormal, Cardiac failure, Computerised tomogram abnormal, Condition aggravated, Cutaneous vasculitis
Clinical narrative: She was admitted with worsening shortness of breath attributed to heart failure, worsening renal failure and rash.  Skin Biopsy showed leukocytoclastic vasculitis.  Renal biopsy pending complicated by perinephric bleeding and hemorrhagic shock.  CT showed pericardial thickening and echo showed possible signs of constrictive pericarditis with septal bounce.
Age: 62.0
Sex: F
Vaccine: COVID19-2
Symptoms: Dyspnoea, Echocardiogram, Pericardial fibrosis, Rash, Renal failure
Clinical narrative: She was admitted with worsening shortness of breath attributed to heart failure, worsening renal failure and rash.  Skin Biopsy showed leukocytoclastic vasculitis.  Renal biopsy pending complicated by perinephric bleeding and hemorrhagic shock.  CT showed pericardial thickening and echo showed possible signs of constrictive pericarditis with septal bounce.
Age: 62.0
Sex: F
Vaccine: COVID19-2
Symptoms: Shock haemorrhagic, Subcapsular renal haematoma
Clinical narrative: She was admitted with worsening shortness of breath attributed to heart failure, worsening renal failure and rash.  Skin Biopsy showed leukocytoclastic vasculitis.  Renal biopsy pending complicated by perinephric bleeding and hemorrhagic shock.  CT showed pericardial thickening and echo showed possible signs of constrictive pericarditis with septal bounce.
Sex: F
Vaccine: HPV9
Symptoms: Papilloma viral infection, Smear cervix abnormal
Clinical narrative: had an abnormal pap smear; tested positive for HPV 16; This spontaneous report was received from a physician via a company representative referring to a female patient of unknown age. Information of the patient's pertinent medical history, concomitant therapy, concurrent condition and drug reactions/allergies was not reported.  On an unknown date, the patient was vaccinated with hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) injection (dose: 0.5 ml, two or three dose series, strength, lot# and expiration date were not reported) intramuscularly (IM) for human papillomavirus infection (HPV) prevention. There was no overdose.  On an unknown date, the patient had an abnormal pap smear (smear cervix abnormal) that tested positive for HPV 16 (human papilloma virus test positive). Date of abnormal pap smear unknown. The HCP did no specify if the completed the series of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9). The HCP did not specify patient's current status or if the patient sought medical attention based on the abnormal pap smear finding. No additional information provided. Consent granted by physician for correspondence regarding this adverse event. No additional AE/PQC reported. At the time of reporting, the outcome of the events was unknown. The causal relationship between the events and hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Death
Clinical narrative: DIED AFTER BLAMING COVID JAB; This spontaneous report received from a consumer via other communication (other source) via a company representative concerned a female of unspecified age, race and ethnicity.  The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, batch number and expiry date were not reported) dose, start therapy date were not reported, 1 total was administered for covid-19 prophylaxis. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On an unspecified date, the patient died from an unknown cause, after blaming the covid jab. It was unknown if an autopsy was performed. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. This report was serious (Death).; Sender's Comments: V0: 20230935238-Died after blaming covid jab. Insufficient information is available to make a causality assessment. Therefore, this event is considered unclassifiable.; Reported Cause(s) of Death: UNKNOWN CAUSE OF DEATH
Age: 70.0
Sex: F
Vaccine: COVID19-2
Symptoms: COVID-19, Pain in extremity
Clinical narrative: sore arm; Covid 19; This spontaneous case was reported by a patient and describes the occurrence of COVID-19 (Covid 19) and PAIN IN EXTREMITY (sore arm) in a 70-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 055F22B) for COVID-19 prophylaxis.     Previously administered products included for Product used for unknown indication: Pfizer vaccine (First dose) on 27-Jan-2021, Pfizer vaccine (Second dose) on 17-Feb-2021 and Pfizer vaccine (Third dose) on 20-Sep-2021. Past adverse reactions to the above products included No adverse event with Pfizer vaccine, Pfizer vaccine and Pfizer vaccine. Concurrent medical conditions included Drug allergy (Codeine). Concomitant products included INFLUENZA VACCINE (FLU VACCINE VII) for an unknown indication.    On 06-Oct-2022, the patient received fifth dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 29-Dec-2022,  after starting mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)), the patient experienced COVID-19 (Covid 19). On an unknown date, the patient experienced PAIN IN EXTREMITY (sore arm). At the time of the report, COVID-19 (Covid 19) had not resolved and PAIN IN EXTREMITY (sore arm) had resolved.            The last shot patient got in Oct they got with the flu shot in the same arm. Second covid diagnosis was on 22-APR-2023 No treatment information was reported.   This case was linked to MOD-2023-741231 (Patient Link).
Age: 89.0
Sex: M
Vaccine: COVID19
Symptoms: Atrial fibrillation, COVID-19 pneumonia, Dyspnoea, Pyrexia
Clinical narrative: Presented from facility with Afib with RVR; SOB/fever x 1 week; dx Covid PNA; treated with steroids, zinc, supplemental O2; discharged home on room air
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site erythema, Injection site swelling, Injection site warmth
Clinical narrative: at site of injection arm was swollen, hot to touch, and red round circle about 1 inch diameter around injection site
Age: 50.0
Sex: F
Vaccine: FLU4
Symptoms: Arthralgia, Hypoaesthesia
Clinical narrative: Employee reports that she had "bizarre numbness on face and down neck." She also reports "bilateral knee pain."
Age: 12.0
Sex: M
Vaccine: MNQ
Symptoms: Injection site erythema, Injection site pain, Injection site swelling
Clinical narrative: pain, warmth, redness, swelling at injection site and about 6" x 4"
Age: 11.0
Sex: M
Vaccine: HPV9, MNQ
Symptoms: Injection site erythema, Peripheral swelling
Clinical narrative: Patient received MCV4 on RD during time of visit arm was swollen and large circle was appeared on injection site. Patient was prescribed Benadryl, Hydrocortisone, Keflex. No other action was taken.
Age: 14.0
Sex: F
Vaccine: COVID19, FLUC4
Symptoms: Headache, Hypoaesthesia, Hypoaesthesia oral, Tremor
Clinical narrative: head hurts, shaking numbness all over including lips and mouth
Age: 59.0
Sex: M
Vaccine: COVID19
Symptoms: Acidosis, Acute respiratory failure, Anion gap increased, Blood bicarbonate, Blood gases
Clinical narrative: Patient with history of COVID vaccination admitted to hospital with COVID detected PCR test. Patient expired on 9/18/2023. Providers discharge summary, "Patient admitted with DKA, likely due to COVID 19, after progressive symptoms for the 10-11 days prior to admission. He reported decreased appetite and PO intake, his high anion gap acidosis was likely combined due to DKA and starvation ketosis. Initially patient started on insulin drip, and when he improved to the point of being able to eat he was given a diet. Subcu insulin started and subsequently his insulin drip was discontinued.   Patient also with acute hypoxic respiratory failure requiring nonrebreather mask and up to 8 L O2. This was able to be weaned down on hospital day one. Patient was treated with antibiotics for possible coinfection with bacterial pneumonia, given his comorbidities and high mortality risk.    This morning I saw the patient and he stated he was feeling well, his breathing was stable and he was requiring only his home 2L O2. His labs were reviewed, and the anion gap had increased again, with noted acidosis with a bicarb of 10. Insulin drip was ordered to restart, and we held his morning subcu insulin.    While waiting for the insulin drip, patient went to the bathroom. When he returned to bed he was noted to be pale and breathing rapidly; nursing notified the team and we came to bedside to evaluate him. He was restarted on nonrebreather mask with no improvement in his symptoms. On my evaluation I heard wheezes in all lung fields but I did appreciate breath sounds. We ordered a stat XR which was done and personally reviewed by myself. Compared to prior it appeared slightly more congested with no obvious effusion, no pneumothorax noted.    RT trialed an albuterol MDI, but due to his rapid breathing he likely had limited benefit. Nebulizer ordered. We also had ordered an ultrasound guided IV line, due to difficulty placing Ivs. ABG also taken, and results reviewed by myself.    Patient noted to have tachycardia to 150s, EKG obtained and I noted sinus rhythm without ST changes. I did order a troponin as the telemetry was occasionally noting Vtach.   Patient suddenly became unresponsive, and nurse called code blue. Less than a minute after unresponsiveness I initiated chest compressions. ICU team arrived shortly after and took over running the code. I spoke with his wife who noted he has signed documents to be full code unless he was without brain function. ICU team continued high quality CPR until it was deemed futile. I spoke with his wife again, offering my condolences, and notified care management to help make arrangements."
Age: 59.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Cardiac telemetry abnormal, Chest X-ray abnormal, Death, Decreased appetite
Clinical narrative: Patient with history of COVID vaccination admitted to hospital with COVID detected PCR test. Patient expired on 9/18/2023. Providers discharge summary, "Patient admitted with DKA, likely due to COVID 19, after progressive symptoms for the 10-11 days prior to admission. He reported decreased appetite and PO intake, his high anion gap acidosis was likely combined due to DKA and starvation ketosis. Initially patient started on insulin drip, and when he improved to the point of being able to eat he was given a diet. Subcu insulin started and subsequently his insulin drip was discontinued.   Patient also with acute hypoxic respiratory failure requiring nonrebreather mask and up to 8 L O2. This was able to be weaned down on hospital day one. Patient was treated with antibiotics for possible coinfection with bacterial pneumonia, given his comorbidities and high mortality risk.    This morning I saw the patient and he stated he was feeling well, his breathing was stable and he was requiring only his home 2L O2. His labs were reviewed, and the anion gap had increased again, with noted acidosis with a bicarb of 10. Insulin drip was ordered to restart, and we held his morning subcu insulin.    While waiting for the insulin drip, patient went to the bathroom. When he returned to bed he was noted to be pale and breathing rapidly; nursing notified the team and we came to bedside to evaluate him. He was restarted on nonrebreather mask with no improvement in his symptoms. On my evaluation I heard wheezes in all lung fields but I did appreciate breath sounds. We ordered a stat XR which was done and personally reviewed by myself. Compared to prior it appeared slightly more congested with no obvious effusion, no pneumothorax noted.    RT trialed an albuterol MDI, but due to his rapid breathing he likely had limited benefit. Nebulizer ordered. We also had ordered an ultrasound guided IV line, due to difficulty placing Ivs. ABG also taken, and results reviewed by myself.    Patient noted to have tachycardia to 150s, EKG obtained and I noted sinus rhythm without ST changes. I did order a troponin as the telemetry was occasionally noting Vtach.   Patient suddenly became unresponsive, and nurse called code blue. Less than a minute after unresponsiveness I initiated chest compressions. ICU team arrived shortly after and took over running the code. I spoke with his wife who noted he has signed documents to be full code unless he was without brain function. ICU team continued high quality CPR until it was deemed futile. I spoke with his wife again, offering my condolences, and notified care management to help make arrangements."
Age: 59.0
Sex: M
Vaccine: COVID19
Symptoms: Diabetic ketoacidosis, Electrocardiogram abnormal, Hypophagia, Intensive care, Pallor
Clinical narrative: Patient with history of COVID vaccination admitted to hospital with COVID detected PCR test. Patient expired on 9/18/2023. Providers discharge summary, "Patient admitted with DKA, likely due to COVID 19, after progressive symptoms for the 10-11 days prior to admission. He reported decreased appetite and PO intake, his high anion gap acidosis was likely combined due to DKA and starvation ketosis. Initially patient started on insulin drip, and when he improved to the point of being able to eat he was given a diet. Subcu insulin started and subsequently his insulin drip was discontinued.   Patient also with acute hypoxic respiratory failure requiring nonrebreather mask and up to 8 L O2. This was able to be weaned down on hospital day one. Patient was treated with antibiotics for possible coinfection with bacterial pneumonia, given his comorbidities and high mortality risk.    This morning I saw the patient and he stated he was feeling well, his breathing was stable and he was requiring only his home 2L O2. His labs were reviewed, and the anion gap had increased again, with noted acidosis with a bicarb of 10. Insulin drip was ordered to restart, and we held his morning subcu insulin.    While waiting for the insulin drip, patient went to the bathroom. When he returned to bed he was noted to be pale and breathing rapidly; nursing notified the team and we came to bedside to evaluate him. He was restarted on nonrebreather mask with no improvement in his symptoms. On my evaluation I heard wheezes in all lung fields but I did appreciate breath sounds. We ordered a stat XR which was done and personally reviewed by myself. Compared to prior it appeared slightly more congested with no obvious effusion, no pneumothorax noted.    RT trialed an albuterol MDI, but due to his rapid breathing he likely had limited benefit. Nebulizer ordered. We also had ordered an ultrasound guided IV line, due to difficulty placing Ivs. ABG also taken, and results reviewed by myself.    Patient noted to have tachycardia to 150s, EKG obtained and I noted sinus rhythm without ST changes. I did order a troponin as the telemetry was occasionally noting Vtach.   Patient suddenly became unresponsive, and nurse called code blue. Less than a minute after unresponsiveness I initiated chest compressions. ICU team arrived shortly after and took over running the code. I spoke with his wife who noted he has signed documents to be full code unless he was without brain function. ICU team continued high quality CPR until it was deemed futile. I spoke with his wife again, offering my condolences, and notified care management to help make arrangements."
Age: 59.0
Sex: M
Vaccine: COVID19
Symptoms: Respiratory rate increased, Respiratory tract congestion, Resuscitation, SARS-CoV-2 test positive, Starvation ketoacidosis
Clinical narrative: Patient with history of COVID vaccination admitted to hospital with COVID detected PCR test. Patient expired on 9/18/2023. Providers discharge summary, "Patient admitted with DKA, likely due to COVID 19, after progressive symptoms for the 10-11 days prior to admission. He reported decreased appetite and PO intake, his high anion gap acidosis was likely combined due to DKA and starvation ketosis. Initially patient started on insulin drip, and when he improved to the point of being able to eat he was given a diet. Subcu insulin started and subsequently his insulin drip was discontinued.   Patient also with acute hypoxic respiratory failure requiring nonrebreather mask and up to 8 L O2. This was able to be weaned down on hospital day one. Patient was treated with antibiotics for possible coinfection with bacterial pneumonia, given his comorbidities and high mortality risk.    This morning I saw the patient and he stated he was feeling well, his breathing was stable and he was requiring only his home 2L O2. His labs were reviewed, and the anion gap had increased again, with noted acidosis with a bicarb of 10. Insulin drip was ordered to restart, and we held his morning subcu insulin.    While waiting for the insulin drip, patient went to the bathroom. When he returned to bed he was noted to be pale and breathing rapidly; nursing notified the team and we came to bedside to evaluate him. He was restarted on nonrebreather mask with no improvement in his symptoms. On my evaluation I heard wheezes in all lung fields but I did appreciate breath sounds. We ordered a stat XR which was done and personally reviewed by myself. Compared to prior it appeared slightly more congested with no obvious effusion, no pneumothorax noted.    RT trialed an albuterol MDI, but due to his rapid breathing he likely had limited benefit. Nebulizer ordered. We also had ordered an ultrasound guided IV line, due to difficulty placing Ivs. ABG also taken, and results reviewed by myself.    Patient noted to have tachycardia to 150s, EKG obtained and I noted sinus rhythm without ST changes. I did order a troponin as the telemetry was occasionally noting Vtach.   Patient suddenly became unresponsive, and nurse called code blue. Less than a minute after unresponsiveness I initiated chest compressions. ICU team arrived shortly after and took over running the code. I spoke with his wife who noted he has signed documents to be full code unless he was without brain function. ICU team continued high quality CPR until it was deemed futile. I spoke with his wife again, offering my condolences, and notified care management to help make arrangements."
Age: 59.0
Sex: M
Vaccine: COVID19
Symptoms: Tachycardia, Troponin, Unresponsive to stimuli, Ventricular tachycardia, Wheezing
Clinical narrative: Patient with history of COVID vaccination admitted to hospital with COVID detected PCR test. Patient expired on 9/18/2023. Providers discharge summary, "Patient admitted with DKA, likely due to COVID 19, after progressive symptoms for the 10-11 days prior to admission. He reported decreased appetite and PO intake, his high anion gap acidosis was likely combined due to DKA and starvation ketosis. Initially patient started on insulin drip, and when he improved to the point of being able to eat he was given a diet. Subcu insulin started and subsequently his insulin drip was discontinued.   Patient also with acute hypoxic respiratory failure requiring nonrebreather mask and up to 8 L O2. This was able to be weaned down on hospital day one. Patient was treated with antibiotics for possible coinfection with bacterial pneumonia, given his comorbidities and high mortality risk.    This morning I saw the patient and he stated he was feeling well, his breathing was stable and he was requiring only his home 2L O2. His labs were reviewed, and the anion gap had increased again, with noted acidosis with a bicarb of 10. Insulin drip was ordered to restart, and we held his morning subcu insulin.    While waiting for the insulin drip, patient went to the bathroom. When he returned to bed he was noted to be pale and breathing rapidly; nursing notified the team and we came to bedside to evaluate him. He was restarted on nonrebreather mask with no improvement in his symptoms. On my evaluation I heard wheezes in all lung fields but I did appreciate breath sounds. We ordered a stat XR which was done and personally reviewed by myself. Compared to prior it appeared slightly more congested with no obvious effusion, no pneumothorax noted.    RT trialed an albuterol MDI, but due to his rapid breathing he likely had limited benefit. Nebulizer ordered. We also had ordered an ultrasound guided IV line, due to difficulty placing Ivs. ABG also taken, and results reviewed by myself.    Patient noted to have tachycardia to 150s, EKG obtained and I noted sinus rhythm without ST changes. I did order a troponin as the telemetry was occasionally noting Vtach.   Patient suddenly became unresponsive, and nurse called code blue. Less than a minute after unresponsiveness I initiated chest compressions. ICU team arrived shortly after and took over running the code. I spoke with his wife who noted he has signed documents to be full code unless he was without brain function. ICU team continued high quality CPR until it was deemed futile. I spoke with his wife again, offering my condolences, and notified care management to help make arrangements."
Age: 86.0
Sex: M
Vaccine: COVID19-2
Symptoms: Breakthrough COVID-19, SARS-CoV-2 test positive
Clinical narrative: COVID Breakthrough Dose 1: 04/07/2021, Moderna, 040B21A Dose 2: 05/05/2021, Moderna, 033C21A Dose 3: 11/19/2021, Moderna, 067F21A
Age: 75.0
Sex: M
Vaccine: COVID19-2
Symptoms: Asthenia, Benign prostatic hyperplasia, Blood creatine phosphokinase increased, COVID-19, Condition aggravated
Clinical narrative: Patient with history of COVID vaccination admitted to hospital with COVID detected PCR test. Provider discharge summary states, "Reason for Admission: h/o  hx of Dm2, colon cancer presented with weakness. He was diagnosed with COVID on PTA ER presentation and was sent home. He sat down on the floor of his house and could not get up from weakness. Labs reveal elevated CPK. Admitted for weakenss from COVID and Rhabdo.    Brief Summary of Hospital Stay: (Include Significant Findings and Invasive Procedures)  Patient has been increasingly improving on IVF and conservative management   Problem list at discharge: Acute Rhabdomyolysis: improving - from prolonged immobilization at home - continue IVF - renal function stable   Acute COVID 19 infection - likely causing weakness - mild URI symptoms. Non hypoxic - symptomatic treatment     Type 2 diabetes mellitus without complications: SSI Benign prostatic hyperplasia without lower urinary tract symptoms: Flomax Essential hypertension: Norvasc, BB PSVT (paroxysmal supraventricular tachycardia)   History of TIA: ASA, statin History of Adenocarcinoma of colon s/p partial colectomy 02/23   Patient was accepted to inpatient Rehab for generalized weakness"
Age: 75.0
Sex: M
Vaccine: COVID19-2
Symptoms: Dysstasia, Essential hypertension, Rhabdomyolysis, SARS-CoV-2 test positive, Supraventricular tachycardia
Clinical narrative: Patient with history of COVID vaccination admitted to hospital with COVID detected PCR test. Provider discharge summary states, "Reason for Admission: h/o  hx of Dm2, colon cancer presented with weakness. He was diagnosed with COVID on PTA ER presentation and was sent home. He sat down on the floor of his house and could not get up from weakness. Labs reveal elevated CPK. Admitted for weakenss from COVID and Rhabdo.    Brief Summary of Hospital Stay: (Include Significant Findings and Invasive Procedures)  Patient has been increasingly improving on IVF and conservative management   Problem list at discharge: Acute Rhabdomyolysis: improving - from prolonged immobilization at home - continue IVF - renal function stable   Acute COVID 19 infection - likely causing weakness - mild URI symptoms. Non hypoxic - symptomatic treatment     Type 2 diabetes mellitus without complications: SSI Benign prostatic hyperplasia without lower urinary tract symptoms: Flomax Essential hypertension: Norvasc, BB PSVT (paroxysmal supraventricular tachycardia)   History of TIA: ASA, statin History of Adenocarcinoma of colon s/p partial colectomy 02/23   Patient was accepted to inpatient Rehab for generalized weakness"
Age: 75.0
Sex: M
Vaccine: COVID19-2
Symptoms: Type 2 diabetes mellitus, Upper respiratory tract infection
Clinical narrative: Patient with history of COVID vaccination admitted to hospital with COVID detected PCR test. Provider discharge summary states, "Reason for Admission: h/o  hx of Dm2, colon cancer presented with weakness. He was diagnosed with COVID on PTA ER presentation and was sent home. He sat down on the floor of his house and could not get up from weakness. Labs reveal elevated CPK. Admitted for weakenss from COVID and Rhabdo.    Brief Summary of Hospital Stay: (Include Significant Findings and Invasive Procedures)  Patient has been increasingly improving on IVF and conservative management   Problem list at discharge: Acute Rhabdomyolysis: improving - from prolonged immobilization at home - continue IVF - renal function stable   Acute COVID 19 infection - likely causing weakness - mild URI symptoms. Non hypoxic - symptomatic treatment     Type 2 diabetes mellitus without complications: SSI Benign prostatic hyperplasia without lower urinary tract symptoms: Flomax Essential hypertension: Norvasc, BB PSVT (paroxysmal supraventricular tachycardia)   History of TIA: ASA, statin History of Adenocarcinoma of colon s/p partial colectomy 02/23   Patient was accepted to inpatient Rehab for generalized weakness"
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Breakthrough COVID-19, SARS-CoV-2 test positive
Clinical narrative: COVID Breakthrough Dose 1: 03/26/2021, Moderna, 030A21A Dose 2: 03/30/2022, Moderna, 048L21A
Age: 75.0
Sex: F
Vaccine: FLU4
Symptoms: Pruritus, Rash
Clinical narrative: Employee complains of rash and itching all over body
Age: 87.0
Sex: F
Vaccine: FLU4
Symptoms: Asthenia, Blood glucose normal, Chills, Constipation, Decreased appetite
Clinical narrative: Patient called 9/20/23 around noontime to inform us that she woke up feeling funny this morning.  She stated having no appetite, being constipated, and experiencing chills.  She did not take her temp so unsure if she had a fever.  She did check her blood glucose before eating anything and it was 177.  Patient is not experiencing any pain at site of injection.  She reported feeling better at the time when she called but still just weak and no appetite.  Patient stated she has not had this type of response to vaccines in the past. After she got off the phone with me she was going to also call her PCP office to inform them as well.
Age: 87.0
Sex: F
Vaccine: FLU4
Symptoms: Feeling abnormal
Clinical narrative: Patient called 9/20/23 around noontime to inform us that she woke up feeling funny this morning.  She stated having no appetite, being constipated, and experiencing chills.  She did not take her temp so unsure if she had a fever.  She did check her blood glucose before eating anything and it was 177.  Patient is not experiencing any pain at site of injection.  She reported feeling better at the time when she called but still just weak and no appetite.  Patient stated she has not had this type of response to vaccines in the past. After she got off the phone with me she was going to also call her PCP office to inform them as well.
Age: 55.0
Sex: F
Vaccine: FLU4
Symptoms: No adverse event, Product administered to patient of inappropriate age
Clinical narrative: I gave high dose flu vaccine to a 55 yo.  No treatment needed.  Patient had no adverse side effects
Age: 18.0
Sex: F
Vaccine: COVID19-2
Symptoms: No adverse event
Clinical narrative: no adverse event reported
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain upper, Nausea
Clinical narrative: Extreme stomach pain within 12 hours of vaccination, nausea, longer-lasting dull/achy stomach pain for two days at this point, but improving slowly.
Age: 37.0
Sex: F
Vaccine: FLU4
Symptoms: Injection site swelling, Oedema peripheral
Clinical narrative: right arm large amount of swelling around upper arm and at axilla area
Age: 46.0
Sex: F
Vaccine: COVID19-2
Symptoms: Discontinued product administered
Clinical narrative: patient was given a covid bivalent vaccine on 09/13/2023 after the date it was no longer authorized.
Age: 48.0
Sex: F
Vaccine: PPV
Symptoms: Hypoaesthesia, Influenza virus test negative, Injection site bruising, Injection site erythema, Injection site pain
Clinical narrative: Swelling on arm near injection site. Swelling looks like red bruise that has grown in side. Started out at 2 inches wide by 1 inch high on Tuesday. Currently on Thursday it is 6 inches wide by 4 includes high covering much of the inside bicep area. Also there are red blotches. The red swelling and blotches hurt when touched. Entire upper arm is painful to move an files like very sore muscles. Some numbness and tingling experience in the fingers on the same arm.
Age: 48.0
Sex: F
Vaccine: PPV
Symptoms: Injection site swelling, Pain, Paraesthesia, Rash macular, SARS-CoV-2 test negative
Clinical narrative: Swelling on arm near injection site. Swelling looks like red bruise that has grown in side. Started out at 2 inches wide by 1 inch high on Tuesday. Currently on Thursday it is 6 inches wide by 4 includes high covering much of the inside bicep area. Also there are red blotches. The red swelling and blotches hurt when touched. Entire upper arm is painful to move an files like very sore muscles. Some numbness and tingling experience in the fingers on the same arm.
Age: 48.0
Sex: F
Vaccine: PPV
Symptoms: White blood cell count increased
Clinical narrative: Swelling on arm near injection site. Swelling looks like red bruise that has grown in side. Started out at 2 inches wide by 1 inch high on Tuesday. Currently on Thursday it is 6 inches wide by 4 includes high covering much of the inside bicep area. Also there are red blotches. The red swelling and blotches hurt when touched. Entire upper arm is painful to move an files like very sore muscles. Some numbness and tingling experience in the fingers on the same arm.
Age: 74.0
Sex: F
Vaccine: RSV
Symptoms: Condition aggravated, Lymphoedema, Peripheral swelling
Clinical narrative: I have lymphedema in my right arm.  My arm and thigh swelled after the RSV vaccination
Age: 69.0
Sex: F
Vaccine: FLU4
Symptoms: Extra dose administered, No adverse event
Clinical narrative: Patient received an additional dose of influenza vaccine. She already received Fluad at her PCP office two days prior. No AE's reported by patient at this time.
Age: 2.0
Sex: F
Vaccine: FLU4
Symptoms: Cough, Cyanosis, Immediate post-injection reaction, Pulmonary function test abnormal, Respiratory rate increased
Clinical narrative: Pt received the flu vaccine in within a minute was gagging, coughing and turning blue. Her lung exam did not reveal wheezing but she was quite restricted with poor air flow. We laid her down with slight improvement in color but still breathing fast and tachycardia. Epipen JR was administered with immediate improvement in symptoms. Albuterol was also given. EMS called and taken to ER. In route to ER she was given benadryl. She was monitored for 4 hours and then sent home.
Age: 2.0
Sex: F
Vaccine: FLU4
Symptoms: Restrictive pulmonary disease, Retching, Tachycardia
Clinical narrative: Pt received the flu vaccine in within a minute was gagging, coughing and turning blue. Her lung exam did not reveal wheezing but she was quite restricted with poor air flow. We laid her down with slight improvement in color but still breathing fast and tachycardia. Epipen JR was administered with immediate improvement in symptoms. Albuterol was also given. EMS called and taken to ER. In route to ER she was given benadryl. She was monitored for 4 hours and then sent home.
Age: 24.0
Sex: M
Vaccine: COVID19-2
Symptoms: Discontinued product administered
Clinical narrative: patient was given a covid bivalent vaccine on 09/13/2023 one day after vaccine was no longer authorized 09/12/2023.
Age: 41.0
Sex: M
Vaccine: ADEN_4_7
Symptoms: Myocarditis
Clinical narrative: Myocarditis